Clinical Trials
3 trialsNCT02535104 2018-06-06
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Tamir Biotechnology, Inc.
Phase 1/2 Completed
NCT01184287 2015-09-02
A Study Of Ranpirnase(OnconaseĀ®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer
Tamir Biotechnology, Inc.
Phase 2 Withdrawn
NCT00003034 2013-11-06
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
National Cancer Institute (NCI)
Phase 3 Unknown